Expert Review

DOI: 10.4244/EIJ-D-24-00972

Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation

Sunny Goel1,2, MD; Richard Tanner1,3, MD; Kwong-yue Eric Chan4, MBBS; Jaffar M. Khan5, MD, PhD; Manish Vinayak1, MD; Stamatios Lerakis1, MD, PhD; Lucy M. Safi1, DO; Sahil Khera1, MD, MPH; Parasuram Krishnamoorthy1, MD; Annapoorna S. Kini1, MD; Samin K. Sharma1, MD; George D. Dangas1, MD, PhD; Gilbert H.L. Tang1,6, MD, MSc, MBA

Abstract

Coronary obstruction is a rare but serious complication during transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, which is associated with high mortality. This review explores various leaflet modification techniques designed to mitigate this risk. Among the most studied methods is Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA), which uses transcatheter electrosurgery to lacerate the aortic valve leaflet and maintain coronary perfusion. Other promising techniques include ShortCut, a mechanical leaflet splitting device, and Undermining Iatrogenic Coronary Obstruction with Radiofrequency Needle (UNICORN), which utilises radiofrequency energy to achieve leaflet laceration. These approaches differ in their procedural complexity, equipment requirements, and clinical outcomes. Each technique’s efficacy in preventing coronary obstruction is discussed, alongside the potential complications and the procedural challenges encountered in both native aortic valve and valve-in-valve settings. This review also highlights the importance of careful patient selection, advanced imaging techniques, and the need for further research to optimise these strategies.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 10
May 16, 2025
Volume 21 Number 10
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00026 Aug 7, 2023
Orthotopic stenting after BASILICA – an indicator of procedural success
Rogers T and Bruce C
free

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free

Clinical research

10.4244/EIJ-D-22-00960 Aug 7, 2023
Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry
Abdel-Wahab M et al
free

10.4244/EIJV16I8A114 Oct 23, 2020
Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction
Rodés-Cabau J and Ribeiro H
free

Original Research

10.4244/EIJ-D-24-00107 Jun 17, 2024
Impact of leaflet splitting on coronary access after redo-TAVI for degenerated supra-annular self-expanding platforms
Beneduce A et al
free
Trending articles
225.25

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.3

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved